Effect of Dientamoeba fragilis eradication on symptoms in children with abdominal pain

Effect of Dientamoeba fragilis eradication on symptoms in children with abdominal pain - Symptoms, Dientamoeba Fragilis and Clioquinol

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30565

Enrollment

Registered

2008-01-14

Start date

2006-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dientamoeba fragilis infection parasitic bowel infection

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: infection with dientamoeba fragilis age between 4 and 18 years old

Exclusion criteria

Exclusion criteria: co-infection with a pathogen IBD (colitis Ulcerosa) Oncologic patients immune compromised patients

Design outcomes

Primary

Measure	Time frame
Change in symptoms in children with dientamoeba fragilis after treatment with clioquinol and placebo. Parasitological eradication	—

Secondary

Measure	Time frame
In de gebruikte duur en dosering van behandeling worden zelden bijwerkingen gezien. In zeer hoge dosering kan het middel neurotoxisch zijn.	—

Countries

Netherlands

Outcome results